| ISSN |
2222-0682 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Anticoagulant use before COVID-19 diagnosis prevent COVID-19 associated acute venous thromboembolism or not: A systematic review and meta-analysis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Kinza Iqbal, Akshat Banga, Taha Bin Arif, Sawai Singh Rathore, Abhishek Bhurwal, Syeda Kisa Batool Naqvi, Muhammad Mehdi, Pankaj Kumar, Mitali Madhu Salklan, Ayman Iqbal, Jawad Ahmed, Nikhil Sharma, Amos Lal, Rahul Kashyap, Vikas Bansal and Juan Pablo Domecq |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Vikas Bansal, MBBS, Associate Research Scientist, Department of Nephrology and Hypertension, Mayo Clinic, 200 1st St SW, Rochester, MN 55905, Rochester, MN 55905, United States. bansal.vikas@mayo.edu |
| Key Words |
Prior anticoagulation; COVID-19; Prehospital anticoagulation; Chronic anticoagulation; Mortality; Severity; Thromboembolic events |
| Core Tip |
Coronavirus disease 2019 (COVID-19) patients are at an increased risk of developing thromboembolic events and hypercoagulable disorders, which are poor prognostic indicators of COVID-19 disease. The results of different observational studies on the effects of chronic anticoagulation on the mortality and severity of COVID-19 disease in infected patients are inconsistent. This systematic review and meta-analysis provide a comprehensive assessment of the risk of thromboembolic events, mortality, and severity of COVID-19 disease in patients on prehospital anticoagulation treatment. |
| Publish Date |
2024-06-25 09:25 |
| Citation |
<p>Iqbal K, Banga A, Arif TB, Rathore SS, Bhurwal A, Naqvi SKB, Mehdi M, Kumar P, Salklan MM, Iqbal A, Ahmed J, Sharma N, Lal A, Kashyap R, Bansal V, Domecq JP. Anticoagulant use before COVID-19 diagnosis prevent COVID-19 associated acute venous thromboembolism or not: A systematic review and meta-analysis. <i>World J Methodol</i> 2024; 14(3): 92983</p> |
| URL |
https://www.wjgnet.com/2222-0682/full/v14/i3/92983.htm |
| DOI |
https://dx.doi.org/10.5662/wjm.v14.i3.92983 |
